By unlocking regenerative potential
Epigenetically reprogramming cells to younger states.
NewLimit is inventing medicines composed of epigenetic reprogramming factors that restore youthful function in old cells. We leverage functional assays, single cell multi-omics, and machine learning to reveal epigenetic features of aging and discover rejuvenating interventions.
Diseases, then longevity
Our 20-year ambition is to significantly extend human healthspan. However, we believe we can develop intermediary epigenetic reprogramming products for patients suffering from diseases today.
We are initially focused on restoring function in the aging immune system.